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Abstract 
AMP-activated protein kinase (AMPK) is a metabolic energy sensor that plays a critical role in 
cancer cell survival and growth. While the physical microenvironment is believed to influence 
tumor growth and progression, its role in AMPK regulation remains largely unknown. In the 
present study, we evaluated AMPK response to mechanical forces and its interaction with other 
mechano-responsive signaling proteins, FAK and Src. Using genetically encoded biosensors that 
can detect AMPK activities at different subcellular locations (cytosol, plasma membrane, 
nucleus, mitochondria, and Golgi apparatus), we observed that AMPK responds to shear stress in 
a subcellular location-dependent manner in breast cancer cells (MDA-MB-231). While normal 
epithelial cells (MCF-10A) also similarly responded to shear stress, they are less sensitive to 
shear stress compared to MDA-MB-231 cells. Inhibition of FAK and Src significantly decreased 
the basal activity level of AMPK at all five subcellular locations in MDA-MB-231 cells and 
selectively blocked shear stress-induced AMPK activation. Moreover, testing with cytoskeletal 
drugs revealed that myosin II might be the critical mediator of shear stress-induced AMPK 
activation in MDA-MB-231 cells. These findings suggest that breast cancer cells and normal 
epithelial cells may have different mechanosensitivity in AMPK signaling and that FAK and Src 
as well as the myosin II-dependent signaling pathway are involved in subcellular AMPK 
mechanotransduction in breast cancer cells. 
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1. Introduction 
The physical tumor microenvironment affects tumor growth and progression[1-3]. As the cancer 
grows, accumulation and reorganization of extracellular matrix and abnormal growth of cancer 
cells result in a buildup of pressure and increased interstitial fluid flow (IFF) within the tumor 
tissue[4]. This IFF in turn generates shear stress to influence cancer cell invasion and 
proliferation possibly via mechanotransduction signaling pathways[5-7]. FAK and Src are such 
mechanotransduction signaling proteins whose activities are increased in cancer cells, thereby 
enhancing tumor growth and metastasis[8].  For example, activation of Src specifically enhances 
the ability of breast cancer cells to grown in bone marrow microenvironment and bone metastasis 
in breast cancer requires Src-dependent survival signals[9]. FAK promotes tumor progression 
and metastasis by controlling cell migration, invasion, survival, and cancer stem cell self-
renewal[10].  While these cellular energy-consuming processes involve Src or FAK, it is unclear 
whether cellular energy homeostasis is related to these signaling proteins. 
 
AMPK regulates cellular energy homeostasis by sensing the ratios of AMP/ATP and 
ADP/ATP[11]. In addition to its major role in cellular energy sensing, AMPK has been shown to 
have multiple roles in cell functions including cell growth, protein synthesis, autophagy, and 
gene transcription[12]. It is increasingly recognized that AMPK’s multiple, and sometimes 
paradoxical, roles in cell physiology as well as pathological diseases such as cancer may be due 
to its compartmentalized subcellular activation because compartmentalization is considered to be 
one of the properties that molecules utilize to conduct multi-tasking[13, 14]. However, it is not 
clear whether distinct subcellular pools of AMPK respond to specific extracellular stimuli. While 
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AMPK is known to be activated by metabolic stress, recent reports have demonstrated that it is 
also activated by mechanical forces, suggesting its involvement in mechanotransduction[15-17]. 
In this study, we used genetically encoded biosensors that are specific to subcellular locations to 
visualize compartmentalized AMPK signaling activities[13]. Fluid flow-induced shear stress was 
applied to two types of the cells, breast cancer cells and normal epithelial cells, to study 
subcellular AMPK responses to mechanical forces. Finally, the role of Src and FAK as well as 
the cytoskeletal components in the shear stress-induced AMPK signaling activities were 
explored to examine the involvement of mechanotransduction in AMPK activities. 
2. Materials and Methods
2.1. Biosensors and plasmids 
FRET-based biosensors for monitoring subcellular compartment-specific AMPK activities were 
kindly provided by Dr. Jin Zhang (University of California San Diego) and Dr. Takanari Inoue 
(Johns Hopkins University). Briefly, the AMPK biosensors are composed of CFP, the FHA1 
domain, the AMPK substrate motif, and YFP. The phosphorylation of the AMPK substrate 
promotes its intramolecular binding to the FHA1 domain, which results in the close association 
of the donor (CFP) and acceptor (YFP) and subsequent FRET from the donor to the acceptor. 
Hence, AMPK activities can be visualized by the changes of the emission ratio of FRET/CFP. 
The different sequences were fused to well-established signal sequences to produce biosensors 
targeting various organelles including cytosol (Cyto-AMPK), plasma membrane (PM-AMPK), 
nucleus (Nuc-AMPK), mitochondria (Mito-AMPK), and Golgi apparatus (Golgi-AMPK)[13]. 
The specificity of these subcellular compartment-specific AMPK biosensors have been 
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extensively tested and their localization has been confirmed using the specific markers[13, 18]. 
The Src and FAK biosensors were kindly provided by Dr. Yingxiao Wang (University of 
California San Diego). The Src biosensor contains the CFP, the SH2 domain from c-Src, the Src 
substrate peptide and YFP[19]. Similarly, the FAK biosensor consists of CFP, the SH2 domain, 
the FAK substrate peptide and YFP[20]. Because the plasma membrane is important in 
mechanotransduction of FAK and Src, we used the biosensors (Lyn-FAK and Lyn-Src) targeted 
to the plasma membrane with a lipid raft-targeting motif, derived from Lyn kinase[21]. The 
CFP/FRET emission ratio was used to measure the activity of Src and FAK.  
 
2.2. Cell culture and transfection 
MDA-MB-231, breast cancer cell lines, were cultured in Dulbecco’s modified Eagle’s medium 
(DMEM; Lonza) containing 10% FBS (Hyclone) and 1% penicillin/streptomycin (Lonza). MCF-
10A cells were cultured in Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12 
(DMEM/F12; Gibco) supplemented with 10% FBS (Hyclone), 1% penicillin/streptomycin 
(Lonza), hydrocortisone (50 µg/ml), insulin (20 µg/ml), and hEGF (200 ng/ml). For imaging 
experiments, cells were plated on a type I collagen-coated glass bottom dish (MatTek) or µ-slide 
cell culture chamber (Ibidi), and then transfected with one of the FRET-based biosensors using 
Lipofectamine LTX (Invitrogen) according to the manufacturer’s protocol. All the cells were 
maintained at 37˚C and 5% CO2   in a humidified incubator prior to experiments. 
 
2.3. Chemical reagents and siRNAs 
PP2 (Sigma; 0.1, 1, 10 µM) was used to inhibit Src activities, and PF-573228 (Sigma; 10, 100, 
1000 nM) was used to inhibit FAK activities. Cytochalasin D (Enzo Life Sciences; 100 ng/ml) 
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was used to disrupt actin filaments. Nocodazole (Sigma; 1 μM) was used to inhibit microtubules.  
Blebbistatin (Toronto Research Chemicals; 50 μM) was used to inhibit myosin II.  ML-7 
(Biomol; 20 μM) was used to inhibit myosin light chain kinase. Compound C (Sigma, 10 μM) 
and A769662 (Tocris, 25 μM) were used as an AMPK inhibitor and activator, respectively. FAK 
siRNA, Src siRNA, and non-specific control (NC) siRNA were obtained from Santa Cruz 
Biotechnology. 
2.4. Shear stress application 
In this study, a unidirectional flow was applied to the cells grown in the µ-slide cell culture 
chamber (Ibidi). We used 2.5 and 10 dynes/cm2 of the shear stress, which was regulated by 
controlling the flow rate of a peristaltic pump (Cole-Parmer). During shear stress application, the 
chamber was perfused with HEPES-buffered, phenol red-free DMEM without serum to maintain 
the pH at 7.4.  The shear stress application experiments were conducted at 37°C by using a 
temperature-controlled air blower (Nevtek). 
2.5. Microscopy and image analysis 
Images were obtained by using a Nikon Ti-E inverted microscope equipped with an Evolve 512 
electron-multiplying charge-coupled device (EMCCD) camera (Photometrics), a filter wheel 
controller (Sutter Instruments), and a Perfect Focus System (Nikon) that maintains the focus 
during time-lapse imaging. The following filter sets (Semrock) were used for FRET imaging: 
CFP excitation: 438/24 (center wavelength/bandwidth in nm); CFP emission: 483/32; YFP 
(FRET) emission: 542/27. To minimize photobleaching, a neutral density (ND) 32 filter was 
used. Time-lapse images were recorded every 2 minutes with a 40× objective with 0.75 
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numerical aperture. FRET images for AMPK, Src, and FAK activity were generated with NIS-
Elements software (Nikon). The FRET ratio images were scaled and represented according to the 
color bar.  
 
2.6. Statistical analysis 
Statistical analyses were conducted using Prism 5 software (GraphPad). Statistical data are 
presented as the mean ± standard error of the mean (SEM). One-way ANOVA followed by 
Dunnett's post hoc test was used to determine the statistical differences among multiple groups, 
and the differences between two groups were evaluated with the two-tailed Student’s t-test. A p 
value less than 0.05 was considered statistically significant.  
 
3. Results 
3.1. Subcellular AMPK response to shear stress in MDA-MB-231 cells 
Several studies have recently reported that AMPK responds to mechanical forces[15, 16]. 
However, little is known about its subcellular response at the single-cell level. Thus, we sought 
to visualize AMPK activities at different subcellular organelles in response to fluid flow-induced 
shear stress. We transfected MDA-MB-231 cells with one of the five FRET-based AMPK 
biosensors: Cyto-AMPK, PM-AMPK, Nuc-AMPK, Mito-AMPK, and Golgi-AMPK targeting 
cytosol, plasma membrane, nucleus, mitochondria, and Golgi apparatus, respectively. The 
AMPK activities were measured by monitoring changes of the FRET/CFP emission ratios of the 
biosensors in the same cell. We observed that shear stress-induced AMPK activities and their 
mechanosensitivity were organelle dependent. (Fig. 1a-e). Cyto-AMPK activities were rapidly 
enhanced by both low (37% increase in 4 min) and high shear stresses (51.4% increase in 2 min). 
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PM-AMPK activities were differently regulated by shear stresses. Under high shear stress, its 
activities were substantially increased (36.8% at 60 min), but under low shear stress, its activities 
were significantly decreased (24.2% at 60 min). Nuc-, Mito-, and Golgi-AMPK activities were 
also upregulated by high shear stress, but not significantly affected by low shear stress. As a 
control, we conducted FRET imaging under shear stress at 0 dyne/cm2, and it did not 
significantly affect AMPK activities in MDA-MB-231 cells (Supplementary Fig. S1a). These 
results indicate that in MDA-MB-231 cells AMPK is activated by shear stress and its activities 
are dependent on the subcellular locations.  
3.2. Subcellular AMPK response to shear stress in MCF-10A cells 
Many lines of evidence suggest that deregulated control of cell population observed in tumor is 
due to the cancer cell’s altered energy metabolism[22]. In this study, we hypothesized that 
AMPK response to shear stress and its activation level in breast cancer cells (MDA-MB-231) 
and normal breast epithelial cells (MCF-10A) might be different. To test his hypothesis, we 
transfected MCF-10A cells with one of the AMPK biosensors and observed AMPK activities 
under shear stress. The results revealed that in MCF-10A cells, Cyto-AMPK activities were 
highly responsive to shear stress, and the activation levels were similar to those of MDA-MB-
231 under both low and high shear stresses (Fig. 2a). However, PM-AMPK and Mito-AMPK in 
MCF-10A cells did not significantly respond to shear stress (Fig. 2b, d). They were initially 
activated by shear stress but returned to the untreated basal levels in 20 minutes. The activation 
pattern and level were significantly different from those observed in MDA-MB-231 (Fig. 1b, d). 
These results suggest that unlike MDA-MB-231 cells, AMPK at the plasma membrane and 
mitochondria is not mechanoresponsive in MCF-10A cells. Nuc-AMPK and Golgi-AMPK were 
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substantially activated by high shear stress (Fig. 2c, e) although to a lesser degree compared to 
the shear stress response in MDA-MB-231 cells (Fig. 1c, e). They did not significantly respond 
to low shear stress, similar to the response in MDA-MB-231 cells. A shear stress at 0 dyne/cm2 
did not significantly affect AMPK activities in MCF-10A cells (Supplementary Fig. S1b). Taken 
together, these results indicate that in response to shear stress, AMPK activity in the specific 
subcellular locations (i.e., plasma membrane and mitochondria) might differently respond to 
shear stress in MDA-MB-231 and MCF-10A cells, suggesting the distinct roles of the subcellular 
location-specific AMPK activation in MDA-MB-231 and MCF-10A cells. 
3.3. Distinct involvement of FAK and Src in subcellular AMPK activities in MDA-MB 231 
and MCF-10A cells 
Our results on AMPK response to shear stress suggest that AMPK might be linked to the 
mechanotransduction signaling pathway such as FAK and Src[23-25]. To test this hypothesis, we 
transfected cells with one of the five AMPK biosensors, and the cells were imaged for 1hour 
under the treatment of FAK inhibitor PF573228 (10, 100, 1000 nM) or Src inhibitor PP2 (0.1, 1, 
10 µM). The highest concentrations of PF573228 (1000 nM) and PP2 (10 µM) used in this study 
have been reported to effectively inhibit FAK and Src, respectively[26-30]. In MDA-MB-231 
cells, AMPK activities in all subcellular locations were significantly decreased under 1000 nM of 
PF573228 (Fig. 3a). Under lower concentrations of PF573228 (10 and 100 nM), only Cyto-
AMPK activities were significantly reduced, while other subcellular AMPK activities were not 
significantly altered (data not shown). AMPK activities were also significantly decreased in all 
subcellular locations under 10 µm of PP2 (Fig. 3b), while they were not altered under lower 
concentrations of PP2 (data not shown). We further confirmed the effects of FAK or Src 
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inhibition on AMPK activity using siRNAs (Supplementary Fig. S2). The results showed similar 
inhibitory effects as compared to those by the specific drugs. In contrast to MDA-MB-231 cells, 
MCF-10A cells showed selective suppression of subcellular AMPK under PF573228 and PP2 
(Fig. 3c, d). AMPK activities at the cytosol, nucleus, and Golgi apparatus were significantly 
decreased by 1000 nM of PF573228 (Fig. 3c), while those at other locations were not 
significantly altered. In response to 10 µM PP2, only the cytosol and nucleus AMPK were 
downregulated, and the Golgi-AMPK was not altered (Fig. 3d). Under lower concentrations of 
the drugs subcellular AMPK activities were not altered (data not shown). The results in Fig. 3 on 
the global inhibition of AMPK in MDA-MB-231 as well as its selective suppression in MCF-
10A under FAK and Src inhibitors are consistent with shear stress-induced subcellular activation 
of AMPK (Figs. 1 and 2), suggesting the distinct role of FAK/Src-mediated 
mechanotransduction in subcellular AMPK activation in MDA-MB-231 and MCF-10A cells.   
 
3.4. Selective blockage of shear stress-induced AMPK activation by inhibition of FAK and 
Src 
To further investigate the significance of shear stress-induced AMPK mechanotransduction, we 
tested whether inhibition of FAK and Src blocks shear stress-induced subcellular AMPK 
activation. Cells transfected with one of the AMPK biosensors were pretreated with 1000 nM 
PF573228 or 10 µM PP2 for 1h prior to FRET imaging. During imaging, cells were subjected to 
10 dyne/cm2 shear stress for 1h. The results revealed that in MDA-MB-231 cells, inhibition of 
FAK and Src by PF573228 and PP2 completely blocked shear stress-induced AMPK activities at 
the plasma membrane, nucleus, and mitochondria, whereas the inhibition did not have a 
significant effect on the shear stress-induced Cyto- and Golgi-AMPK activities (Fig. 4a). MCF-
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10A cells showed a different response (Fig. 4b). Although PF573228 and PP2 appeared to 
partially block shear stress-induced AMPK activities in Cyto-AMPK, they failed to completely 
block the activities. Golgi-AMPK in MCF-10A cells was also not affected by the two drugs. 
Consistent with the results shown in Figs 2 and 3, PF573228 and PP2 did not affect shear stress-
induced PM- and Mito-AMPK. Only shear stress-induced Nuc-AMPK activities were 
completely blocked by PF573228 and PP2 in MCF-10A cells.  
3.5. The role of the cytoskeleton in the regulation of shear stress-induced AMPK activities 
The cytoskeleton and its associated activity have been shown to serve as a critical mediator for 
cellular mechanotransduction[23, 31]. Thus, we next sought to address the mechanism by which 
they affect shear stress-induced AMPK activity. Cells expressing one of the AMPK biosensors 
were pretreated for 1 hour with one of the reagents that specifically disrupt or inhibit actin 
filaments (cytochalasin D), microtubules (nocodazole), myosin light chain kinase (ML-7), or 
myosin II activity (blebbistatin). During FRET imaging, shear stress was applied to the cells. 
Significant suppression of the shear stress-induced Cyto-AMPK activation was observed in both 
MDA-MB-231 and MCF10A cells pretreated with cytochalasin D, nocodazole, ML-7, and 
blebbistatin (Fig. 5a). Interestingly, shear stress-induced PM-AMPK activation was not altered 
by cytochalasin D, while other drugs significantly suppressed the activation in MDA-MB-231 
cells (Fig. 5b). We observed that PM-AMPK in MCF-10A cells did not respond to shear stress 
(Fig. 2b). Similarly, none of the cytoskeletal drugs failed to alter its activation under shear stress 
(Fig. 5b). Shear stress-induced Nuc-AMPK in both cell types was substantially decreased by all 
of the cytoskeletal drugs used in this study (Fig. 5c). In MDA-MB-231 cells, Mito-AMPK was 
significantly activated by shear stress and this activation was suppressed by cytochalasin D, 
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nocodazole, ML-7, and blebbistatin (Fig. 5d). In MCF-10A cells, however, Mito-AMPK was not 
significantly altered by shear stress and other cytoskeletal drugs (Fig. 5d). Although all 
cytoskeletal drugs suppressed shear stress-induced Golgi-AMPK activation in MDA-MB-231 
cells, ML-7 and blebbistatin appeared to completely block the activation (Fig. 5e). The 
cytoskeletal drugs did not affect shear stress-induced activation of Golgi-AMPK in MCF-10A 
cells (Fig. 5e). These results suggest the potentially distinct role of the cytoskeleton and its 
associated activity in subcellular AMPK activation. 
 
3.6. The role of AMPK in the activities of FAK and Src  
AMPK has been reported to negatively regulate integrin b1[32, 33]. Since integrin b1 plays a 
critical role in FAK- and Src-mediated mechanotransduction[8, 23, 34], we sought to test the role 
of AMPK in FAK and Src activation. First, we measured the basal level of FAK and Src in 
response to AMPK activation and inhibition. Cells expressing the FAK or Src biosensor were 
treated with either 25 µM A769662 (an AMPK activator) or 10 µM Compound C (an AMPK 
inhibitor) for 1 h and then the basal levels of FAK and Src activation were compared with the 
non-treated control group. The results revealed that in MDA-MB-231 cells, the basal levels of 
both FAK and Src were substantially reduced by AMPK activation, while they were enhanced by 
AMPK inhibition (Fig. 6a). Similarly, MCF-10A cells showed a significant inhibition of the 
basal level of FAK and Src under AMPK activation. However, AMPK inhibition did not alter 
their basal levels in MCF-10A cells (Fig. 6b). Next, we tested the role of AMPK in the 
mechanotransduction of FAK and Src. Shear stress significantly increased FAK activity in both 
MDA-MB-231 and MCF-10A cells and this FAK mechanotransduction was not significantly 
affected by pretreatment of A769662 and Compound C (Fig. 6c). Src activity was also enhanced 
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by shear stress in both MDA-MB-231 and MCF-10A cells (Fig. 6d). Interestingly, while 
pretreatment of A769662 did not affect Src mechanotransduction, Compound C completely 
blocked it (Fig. 6d). These results indicate that AMPK affects the basal level of FAK and Src 
activation, but it does not significantly affect shear stress-induced activation of FAK and Src. 
4. Discussion
In this study, we used the subcellular compartment-specific AMPK biosensors to explore 
mechanotransduction of subcellular AMPK and its interaction with FAK and Src. The aim of this 
study is to visualize subcellular compartment-specific AMPK activity with high spatial and 
temporal precision using FRET-based biosensors. It has been demonstrated that the FRET-based 
biosensors allow for monitoring, in real time, phosphorylation of proteins in living cells, without 
the need to lyse cells for biochemical characterization[35, 36]. In recent reports describing the 
development of the AMPK FRET biosensor showed that the AMPK activity measured by the 
FRET biosensor was specific to AMPK, and similar to that measured by phosphorylation 
status[13, 37]. We showed that AMPK responds to mechanical forces, and that its subcellular 
compartment-specific responses are different between breast cancer cells and normal epithelial 
cells. Several studies demonstrated mechanical force-induced AMPK activation. For example, in 
vascular endothelial cells, shear stress-induced AMPK activation is shown to regulate vascular 
homeostasis by increasing eNOS (endothelial nitric oxide synthase; vasodilator) and decreasing 
ET-1 (endothelin 1; vasoconstrictor)[16]. ATP is released by shear stress to mediate eNOS in 
endothelial cells [38]. In epithelial cells, mechanical force applied to E-cadherin induces AMPK 
activation which contributes to junction reinforcement via increased E-cadherin and F-actin 
enrichment at tight junctions[15]. These studies quantified the level of global AMPK activities in 
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a group of cells. However, several lines of evidence indicate distinct subcellular localization of 
AMPK within a cell, such as nucleus[39] and mitochondria[17], and AMPK shuttling between 
nucleus and cytoplasm is influenced by environmental stresses such as heat shock or oxidant 
exposure[40]. Thus, we postulated that AMPK response to mechanical force may be dependent 
on subcellular location. In the present study, we observed that MDA-MB-231 and MCF-10A 
cells exhibit highly distinct subcellular AMPK activation patterns in response to fluid flow. 
Specifically, AMPK response at the plasma membrane and mitochondria was enhanced in MDA-
MB-231 cells, but not in MCF-10A cells under fluid flow. Little is known about the molecular 
mechanism of these distinct AMPK responses between cancer and normal cells under flow. 
Moreover, the role of AMPK at the specific subcellular compartments in cell behaviors is yet to 
be determined. Recent reviews suggested that compartment-specific regulation of AMPK might 
play a role in AMPK’s final biological output, and subsequently cell behaviors [14, 41]. It has 
been reported that cancer cells use altered glucose metabolism at the mitochondria for energy 
homeostasis and survival [42, 43] and that mitochondria-targeted AMPK is involved in cell 
growth survival[44, 45]. We have also recently showed that AMPK in the mitochondria is 
activated by interstitial fluid flow in three-dimensional culture and that mitochondrial AMPK 
inhibition reduced cell migration and blocked flow-induced cell migration[17]. Given the 
context-dependent role for AMPK in cancer, which can exert pro- or anti-tumorigenic effects, 
there is a pressing need to investigate whether and how subcellular AMPK complexes contribute 
to AMPK-mediated downstream effects that may consequently determine the balance between 
tumor-suppressive or oncogenic AMPK signaling.  
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Many studies reported that FAK and Src are the primary nodes in mechanotransduction signaling 
pathways[8, 23, 24, 46, 47]. However, little is known about their involvement in 
mechanotransduction of AMPK. Here we showed their potentially distinct roles in MDA-MB-
231 and MCF-10A cells. While all the subcellular AMPK activities tested were downregulated 
by the specific FAK and Src inhibitors in MDA-MB-231 cells, MCF-10A cells showed selective 
AMPK reduction under the inhibitors. We observed that some of the AMPK biosensors showed 
small FRET ratio changes under the FAK or Src inhibitor, although the results were statistically 
significant. While it is not clear whether these small changes would consequently affect cell 
behavior, previous studies have shown that the typical FRET ratio changes are in the range of 
10-20% in response to extracellular stimuli that are known to affect cell behavior[13, 17, 23-25].
This range is consistent with our present study. The FAK and Src inhibitors blocked AMPK 
response to shear stress at the plasma membrane, nucleus, and mitochondria in MDA-MB-231 
cells, whereas they only blocked AMPK at the nucleus in MCF-10A cells. Our data suggest that 
there may be differential FAK/Src-driven mechanosensitivity between cancer cells and normal 
cells[48]. Our data also indicate that shear stress-induced activities of Cyto- and Golgi-AMPK in 
MDA-MB-231 and MCF-10A were independent of FAK and Src. Other signaling proteins such 
as Piezos[49] or cellular structural integrity such as membrane fluidity[50] might be involved in 
this FAK/Src-independent AMPK activation by shear stress.  
We observed in the present study that myosin II activity is essential for shear stress-induced 
AMPK activation. While incubation with other cytoskeletal drugs that specifically target actin 
filaments and microtubules partially inhibited subcellular AMPK activation under shear stress, 
ML-7 and blebbistatin that inhibit myosin II activity abrogated shear stress-induced AMPK
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activation regardless of subcellular AMPK locations. These results are consistent with a recent 
report suggesting that RhoA-ROCK-myosin II pathway is necessary for force-induced AMPK 
mechanotransduction[15]. Collectively, the cellular contractility pathway appears to play a 
critical role in force-induced AMPK activation[51].    
Consistent with recent reports demonstrating the role of AMPK in the negative regulation of 
integrin β1[32, 33], our data show that AMPK activation by A769662 significantly reduced the 
basal activity of FAK and Src. Together with the results in the present study on the regulation of 
AMPK by FAK and Src, there appears to be a feedback loop between FAK/Src and AMPK 
activities. However, our data suggest that although AMPK affects the basal level of FAK and 
Src, it does not play a critical role in shear stress-induced activation of FAK and Src. It is 
possible that AMPK-driven integrin b1 inhibition is not sufficient to mediate 
mechanotransduction of FAK and Src and other integrins such as avb3 [52, 53] might be 
involved in shear stress-induced activation of FAK and Src. 
5. Conclusions
Our results show that while cytosolic AMPK, the majority AMPK pool, is activated by shear 
stress in MDA-MB-231 and MCF-10A cells, these two cells have different subcellular AMPK 
activation patterns, suggesting the different mechanoresponsive metabolic signaling between 
breast cancer cells and normal epithelial cells. Importantly, FAK and Src as well as the myosin 
II-dependent signaling pathway appear to be involved in subcellular AMPK
mechanotransduction. In the future, it will be of interest to investigate how individual 
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extracellular stimuli affects specific subcellular pool of AMPK, which in turn influences cancer 
cell behavior, such as cell survival, migration, proliferation, and autophagy. 
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Figure Legend 
Figure 1. AMPK activities at each subcellular compartment in response to fluid flow-induced 
shear stress in MDA-MB-231 cells. (a) Cyto-AMPK activities. 2.5 dyne/cm2, n=11; 10 
dyne/cm2, n=11. (b) PM-AMPK activities. 2.5 dyne/cm2, n=7; 10 dyne/cm2, n=9. (c) Nuc-AMPK 
activities. 2.5 dyne/cm2, n=10; 10 dyne/cm2, n=9. (d) Mito-AMPK activities 2.5 dyne/cm2, n=9; 
10 dyne/cm2, n=14. (e) Golgi-AMPK activities. 2.5 dyne/cm2, n=14; 10 dyne/cm2, n=13. Scale 
bars, 10 µm. 
 
Figure 2. AMPK activities at each subcellular compartment in response to fluid flow-induced 
shear stress in MCF-10A cells. (a) Cyto-AMPK activities. 2.5 dyne/cm2, n=8; 10 dyne/cm2, 
n=12. (b) PM-AMPK activities. 2.5 dyne/cm2, n=9; 10 dyne/cm2, n=9. (c) Nuc-AMPK activities. 
2.5 dyne/cm2, n=10; 10 dyne/cm2, n=10. (d) Mito-AMPK activities. 2.5 dyne/cm2, n=8; 10 
dyne/cm2, n=11. (e) Golgi-AMPK activities. 2.5 dyne/cm2, n=11; 10 dyne/cm2, n=12. Scale bars, 
10 µm. 
 
Figure 3. AMPK activities at each subcellular compartment under PF573228 and PP2. (a) 
AMPK activities in response to PF573228 in MDA-MB231 cells. n>8. (b) AMPK activities in 
response to PP2 in MDA-MB231 cells. n>10.  (c) AMPK activities in response to PF573228 in 
MCF-10A cells. n>9.  (d) AMPK activities in response to PP2 in MCF-10A cells. n>9.  Scale 
bars, 10 µm. * p<0.05, ** p<0.01, and *** p<0.001 compared to the corresponding FRET 
activities at 0 min. 
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Figure 4. The flow-driven activities of AMPK after pre-treatment with PF573228 and PP2. Cells 
transfected with one of the AMPK biosensors were pretreated with either 1000 nM PF573228 or 
10 µM PP2 for 1 hour before application of fluid flow-induced shear stress. Each bar graph 
represents corresponding compartmentalized AMPK activities at 60 min that were normalized to 
those at 0 min. (a) AMPK activities in MDA-MB231 cells. Under 10 dyne/cm2 + PF573228: 
Cyto-AMPK, n=9; PM-AMPK, n=10; Nuc-AMPK, n=13; Mito-AMPK, n=12; Golgi-AMPK, 
n=10. Under 10 dyne/cm2 + PP2: Cyto-AMPK, n=12; PM-AMPK, n=8; Nuc-AMPK, n=12; 
Mito-AMPK, n=14; Golgi-AMPK, n=10. (b) AMPK activities in MCF-10A cells. Under 10 
dyne/cm2 + PF573228: Cyto-AMPK, n=13; PM-AMPK, n=12; Nuc-AMPK, n=13; Mito-AMPK, 
n=15; Golgi-AMPK, n=13. Under 10 dyne/cm2 + PP2: Cyto-AMPK, n=11; PM-AMPK, n=14; 
Nuc-AMPK, n=11; Mito-AMPK, n=14; Golgi-AMPK, n=11. The number of samples under 10 
dyne/cm2 alone in (a) and (b) is shown in Figs. 1 and 2, respectively. Scale bars, 10 µm. * 
p< 0.05, • p < 0.01, and + p < 0.001 compared to the corresponding FRET activities at 0 min. 
Figure 5. The role of the cytoskeletal components in the regulation of shear stress-induced 
AMPK activities. Cells transfected with one of the AMPK biosensors were pretreated with one 
of the reagents (Cytochalasin D, Nocodazole, ML-7, or Blebbistatin) for 1 hour before FRET 
imaging. Each bar graph represents corresponding compartmentalized AMPK activities at 60 
min that were normalized to those at 0 min. (a) Cyto-AMPK activity. (b) PM-AMPK activity. (c) 
Nuc-AMPK activity. (d) Mito-AMPK activity. (e) Golgi-AMPK activity. n=10~23 cells. * 
p<0.05, ** p<0.01, *** p<0.001 compared to the control group. 
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Figure 6. The role of AMPK in the activities of FAK and Src. (a) The basal level of FAK and 
Src activities of three different treatment groups in MDA-MB-231 cells. In the Lyn-FAK: 
Control, n=11; A769662, n=16; Compound C, n=14. In the Lyn-Src: Control, n=14; A769662, 
n=13; Compound C, n=17. (b) The basal level of FAK and Src activities of three different 
treatment groups in MCF-10A cells. In the Lyn-FAK: Control, n=28; A769662, n=17; 
Compound C, n=16. In the Lyn-Src: Control, n=18; A769662, n=15; Compound C, n=18. (c-d) 
Mechanotransduction of FAK and Src under treatment of AMPK activator and inhibitor. Cells 
transfected with either Lyn-FAK or Lyn-Src were pretreated with either an AMPK activator 
(A769662) or inhibitor (Compound C) for 1 hour before FRET imaging. The bar graphs were 
normalized to the corresponding biosensor and treatment group at 0 min. (c) FAK activities. In 
MDA-MB-231: shear stress alone, n=17; shear stress + A769662, n=17; shear stress + 
Compound C, n=14. In MCF-10A: shear stress alone, n=20; shear stress + A769662, n=21; shear 
stress + Compound C, n=17. (d) Src activities. In MDA-MB-231: shear stress alone, n=11; shear 
stress + A769662, n=13; shear stress + Compound C, n=13. In MCF-10A: shear stress alone, 
n=11; shear stress + A769662, n=16; shear stress + Compound C, n=13. Scale bars, 10μm. * 
p<0.05, ** p<0.01, *** p<0.001 compared to the control group in (a-b) and corresponding FRET 
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Figure S1. AMPK activities at each subcellular compartment under fluid flow-induced shear 
stress at 0 dyne/cm2. (a) MDA-MB-231 cells. n>12. (b) MCF-10A cells. n>10.   
  
 
Figure S2. The basal level of AMPK activities at each subcellular compartment in MDA-MB-
231 cells transfected with negative control (NC), FAK siRNA, or Src siRNA. n>12. * p<0.05, ** 
p<0.01, *** p<0.001. Scale bars, 10 µm.  
 
